Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Cancer Therapies02:49

Cancer Therapies

10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
Hypoxia01:23

Hypoxia

2.6K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Advanced AI Frameworks for Dual PPAR α/γ Agonist Discovery in Alzheimer's Disease.

ACS chemical neuroscience·2026
Same author

Longifolene mitigates amyloid beta induced neurotoxicity by acting on PI3K/AKT/NFκB pathway: Comprehensive in vitro, in vivo pharmacokinetics and pharmacodynamic studies for Alzheimer's disease.

European journal of pharmacology·2026
Same author

Ethanol-assisted fabrication of Casein-Ritonavir amorphous dispersions.

Food hydrocolloids for health·2026
Same author

Exploring the terahertz absorption spectra of aqueous guanidinium chloride solutions using polarizable models for water and the salt.

Physical chemistry chemical physics : PCCP·2026
Same author

Folate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies.

International immunopharmacology·2026
Same author

Neuroinflammation mediated repurposing of clemastine for Alzheimer's disease through network pharmacology, molecular dynamics, and experimental validation studies.

Inflammopharmacology·2026

Related Experiment Video

Updated: Apr 14, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

86.8K

Curcumin: Promising Modulator of Hypoxia Signaling in Cancer.

Tejveer Singh1, Deepika Sharma1, Shubham Adhikari2

  • 1Translational Oncology Laboratory, Department of Zoology, Hansraj College, Delhi University, New Delhi, India.

Journal of Biochemical and Molecular Toxicology
|April 13, 2026
PubMed
Summary

Curcumin, a natural compound, effectively inhibits cancer cell growth and spread by targeting hypoxia pathways. This research highlights curcumin

Keywords:
curcuminhypoxiananoformulationsredox modulationtranscription factors

More Related Videos

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

86.8K
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Solid tumors frequently exhibit hypoxia, a condition that fuels tumor progression and metastasis.
  • Understanding cellular oxygen sensing and homeostasis is vital for cancer research and treatment.
  • Targeting hypoxia-inducible pathways presents a promising therapeutic strategy in oncology.

Purpose of the Study:

  • To explore the potential of curcumin as an inhibitor of molecular targets crucial for hypoxia-induced cancer cell survival.
  • To elucidate the role of curcumin in modulating the tumor microenvironment and its impact on malignancy.

Main Methods:

  • Review of existing studies on curcumin's effects on cancer signaling pathways.
  • Analysis of curcumin's inhibitory action on key molecular targets involved in hypoxia.
  • Investigation of curcumin's influence on hypoxia-driven cancer cell proliferation and metastasis.

Main Results:

  • Curcumin demonstrated significant inhibition of critical signaling pathways, including PI3K/Akt, AMPK-mTOR, and NF-κB.
  • These pathways are integral to preventing the spread of hypoxia-induced cancers.
  • Curcumin alters the tumor microenvironment, impacting the course of malignancy.

Conclusions:

  • Curcumin shows promise as a chemopreventive agent by inactivating hypoxia.
  • Its ability to inhibit key molecular targets essential for cancer cell survival underscores its potential as a tumor-static drug.
  • Further research into curcumin's anticancer effects is warranted.